Ramy Abdelnaby: The Impact of Multiterritory Brain Infarcts on Recurrent Stroke Risk and Anticoagulation Efficacy
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Rachel Gologorsky et al, published in Stroke Journal:
”A pivotal subgroup analysis of the ARCADIA trial, recently published in Stroke, illuminates the impact of multiterritory brain infarcts on recurrent stroke risk and the efficacy of anticoagulation in cryptogenic stroke patients.
The comprehensive study spanned from 2018 to 2022 across 185 centers, exploring atrial cardiopathy’s role in stroke recurrence and anticoagulation response.
Key findings reveal no significant association between atrial cardiopathy biomarkers, LVEF, and the number of infarct territories.
Yet, it’s the detailed examination of recurrent stroke risk and anticoagulation effects that promises to redefine clinical strategies.”
Title: Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Authors: Rachel Gologorsky, Maarten G. Lansberg, Max Wintermark, Christy N. Cassarly, Rebeca Aragon Garcia, Pamela Plummer, Nilushi Karunamuni, Scott E. Kasner, Babak B. Navi, Ava Liberman, Mukul Sharma, Joseph P. Broderick, W.T. Longstreth Jr., David L. Tirschwell, Richard A. Kronmal, Mitchell S.V. Elkind, Hooman Kamel
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026